Canaccord Genuity initiated coverage on GRAIL with a new price target
$GRAL
Medical Specialities
Health Care
Canaccord Genuity initiated coverage of GRAIL with a rating of Buy and set a new price target of $32.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2025 | $32.00 | Buy | Canaccord Genuity |
| 11/27/2024 | $16.00 | Equal-Weight | Morgan Stanley |
| 11/15/2024 | Peer Perform | Wolfe Research | |
| 10/17/2024 | Neutral | Guggenheim |